BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 7678076)

  • 1. Characterization of lineage-negative blast subpopulations derived from normal and chronic myelogenous leukemia bone marrows and determination of their responsiveness to human c-kit ligand.
    Strife A; Perez A; Lambek C; Wisniewski D; Bruno S; Darzynkiewicz Z; Clarkson B
    Cancer Res; 1993 Jan; 53(2):401-9. PubMed ID: 7678076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant growth of granulocyte-macrophage progenitors in juvenile chronic myelogenous leukemia in serum-free culture.
    Sawai N; Koike K; Ito S; Okumura N; Kamijo T; Shiohara M; Amano Y; Tsuji K; Nakahata T; Oda M
    Exp Hematol; 1996 Feb; 24(2):116-22. PubMed ID: 8641332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-kit ligand stimulates tyrosine phosphorylation of a similar pattern of phosphotyrosyl proteins in primary primitive normal hematopoietic progenitors that are constitutively phosphorylated in comparable primitive progenitors in chronic phase chronic myelogenous leukemia.
    Wisniewski D; Strife A; Berman E; Clarkson B
    Leukemia; 1996 Feb; 10(2):229-37. PubMed ID: 8637231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of TGF-beta 1 on normal and leukemic human hematopoietic cell proliferation.
    Murohashi I; Endho K; Nishida S; Yoshida S; Jinnai I; Bessho M; Hirashima K
    Exp Hematol; 1995 Aug; 23(9):970-7. PubMed ID: 7543418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expansion of neutrophil precursors and progenitors in suspension cultures of CD34+ cells enriched from human bone marrow.
    Smith SL; Bender JG; Maples PB; Unverzagt K; Schilling M; Lum L; Williams S; Van Epps DE
    Exp Hematol; 1993 Jul; 21(7):870-7. PubMed ID: 7686502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM; Gulati SC
    Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe functional alterations in vitro in CD34(+) cell subpopulations from patients with chronic myeloid leukemia.
    Chávez-González A; Rosas-Cabral A; Vela-Ojeda J; González JC; Mayani H
    Leuk Res; 2004 Jun; 28(6):639-47. PubMed ID: 15120942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
    Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G-CSF and GM-CSF concentrations and receptor expression in peripheral blood leukemic cells from patients with chronic myelogenous leukemia.
    Lee J; Kim Y; Lim J; Kim M; Han K
    Ann Clin Lab Sci; 2008; 38(4):331-7. PubMed ID: 18988925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of G-CSF on the proliferation and differentiation of bcr/abl(+)-CD34+ cells from CML patients].
    Li CY; Meng FY; Sun QX; Fu YB; Jiang QL; Yi ZS; Song LL
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):762-5. PubMed ID: 18457269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematologic effects of stem cell factor alone and in combination with G-CSF and GM-CSF in vivo and in vitro in rodents.
    Ulich TR; Yi ES; Yin S; del Castillo J; McNiece I; Yung YP; Zsebo KM
    Int Rev Exp Pathol; 1993; 34 Pt A():215-33. PubMed ID: 7681048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte-macrophage colony-stimulating factor modulation of the inhibitory effect of transforming growth factor-beta on normal and leukemic human hematopoietic progenitor cells.
    Cashman JD; Eaves AC; Eaves CJ
    Leukemia; 1992 Sep; 6(9):886-92. PubMed ID: 1518302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.
    Ferret-Bernard S; Saï P; Bach JM
    Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte-colony stimulating factor and stem cell factor are the crucial factors in long-term culture of human primitive hematopoietic cells supported by a murine stromal cell line.
    Nishi N; Ishikawa R; Inoue H; Nishikawa M; Kakeda M; Yoneya T; Tsumura H; Ohashi H; Yamaguchi Y; Motoki K; Sudo T; Mori KJ
    Exp Hematol; 1996 Sep; 24(11):1312-21. PubMed ID: 8862442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1.
    McCrady CW; Li F; Pettit GR; Grant S
    Exp Hematol; 1993 Jul; 21(7):893-900. PubMed ID: 7686503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular characteristics of chronic myelocytic leukemia basophilic crisis cells: phenotype, responsiveness to and receptor gene expression for various kinds of growth factors and cytokines.
    Shimizu N; Kita K; Masuya M; Nishii K; Matsuoka N; Morita N; Miwa H; Shirakawa S
    Exp Hematol; 1993 Jan; 21(1):119-25. PubMed ID: 7678084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discordant maturation as the primary biological defect in chronic myelogenous leukemia.
    Strife A; Lambek C; Wisniewski D; Wachter M; Gulati SC; Clarkson BD
    Cancer Res; 1988 Feb; 48(4):1035-41. PubMed ID: 3422181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetal bone marrow CD34+CD41+ cells are enriched for multipotent hematopoietic progenitors, but not for pluripotent stem cells.
    Murray LJ; Mandich D; Bruno E; DiGiusto RK; Fu WC; Sutherland DR; Hoffman R; Tsukamoto A
    Exp Hematol; 1996 Feb; 24(2):236-45. PubMed ID: 8641347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.